LU87414A1 - Derives de l'adenosine - Google Patents

Derives de l'adenosine Download PDF

Info

Publication number
LU87414A1
LU87414A1 LU87414A LU87414A LU87414A1 LU 87414 A1 LU87414 A1 LU 87414A1 LU 87414 A LU87414 A LU 87414A LU 87414 A LU87414 A LU 87414A LU 87414 A1 LU87414 A1 LU 87414A1
Authority
LU
Luxembourg
Prior art keywords
formula
compound
radical
compounds
physiologically acceptable
Prior art date
Application number
LU87414A
Other languages
English (en)
French (fr)
Inventor
Evans Brian
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of LU87414A1 publication Critical patent/LU87414A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
LU87414A 1987-12-23 1988-12-23 Derives de l'adenosine LU87414A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878729994A GB8729994D0 (en) 1987-12-23 1987-12-23 Chemical compounds
GB8729994 1987-12-23

Publications (1)

Publication Number Publication Date
LU87414A1 true LU87414A1 (fr) 1989-07-07

Family

ID=10628947

Family Applications (1)

Application Number Title Priority Date Filing Date
LU87414A LU87414A1 (fr) 1987-12-23 1988-12-23 Derives de l'adenosine

Country Status (36)

Country Link
US (1) US5032583A (it)
EP (1) EP0322242B1 (it)
JP (1) JP2736088B2 (it)
KR (1) KR890009967A (it)
CN (1) CN1024198C (it)
AT (1) ATA315488A (it)
AU (2) AU612747B2 (it)
BE (1) BE1002167A5 (it)
CA (1) CA1320195C (it)
CH (1) CH677495A5 (it)
CZ (1) CZ403991A3 (it)
DE (2) DE3856154T2 (it)
DK (1) DK170894B1 (it)
ES (1) ES2012927A6 (it)
FI (1) FI90429C (it)
FR (1) FR2629715B1 (it)
GB (2) GB8729994D0 (it)
GR (1) GR1000307B (it)
HK (1) HK1009650A1 (it)
HU (1) HU203364B (it)
IE (1) IE61302B1 (it)
IL (1) IL88765A (it)
IT (1) IT1224840B (it)
LU (1) LU87414A1 (it)
MX (1) MX14331A (it)
NL (1) NL8803140A (it)
NO (1) NO171506C (it)
NZ (1) NZ227485A (it)
PH (1) PH25932A (it)
PL (1) PL158800B1 (it)
PT (1) PT89328B (it)
RU (2) RU1826971C (it)
SE (1) SE8804609L (it)
SG (1) SG44701A1 (it)
YU (1) YU234188A (it)
ZA (1) ZA889593B (it)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2226027B (en) * 1988-12-13 1992-05-20 Sandoz Ltd Adenosine derivatives,their production and use
FR2665362B1 (fr) * 1990-08-03 1994-12-09 Cepbepe Substance contenant, comme principe actif, une adenosine substitutee en n6 et son application.
ES2095960T3 (es) * 1990-09-25 1997-03-01 Rhone Poulenc Rorer Int Compuestos que tienen propiedades antihipertensivas y antiisquemicas.
US5561134A (en) * 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
GB9111580D0 (en) * 1991-05-30 1991-07-24 Wellcome Found Nucleoside derivative
DK62692D0 (it) * 1992-05-14 1992-05-14 Novo Nordisk As
US5672588A (en) * 1992-05-20 1997-09-30 Novo Nordisk A/S Purine derivatives
US5443836A (en) * 1993-03-15 1995-08-22 Gensia, Inc. Methods for protecting tissues and organs from ischemic damage
BR9507683A (pt) * 1994-05-10 1997-09-23 Sandoz Ag Derivados de adenosina
GB9421133D0 (en) * 1994-10-20 1994-12-07 Glaxo Group Ltd Medicaments
WO1997033591A1 (en) * 1996-03-13 1997-09-18 Novo Nordisk A/S A method of treating disorders related to cytokines in mammals
WO1997033590A1 (en) * 1996-03-13 1997-09-18 Novo Nordisk A/S A method of treating disorders related to cytokines in mammals
US6376472B1 (en) * 1996-07-08 2002-04-23 Aventis Pharmaceuticals, Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
BR9911612A (pt) 1998-06-02 2001-02-06 Osi Pharm Inc Composições de pirrolo[2,3d]pirimidina e seus usos
US6878716B1 (en) 1998-06-02 2005-04-12 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptor and uses thereof
US6686366B1 (en) 1998-06-02 2004-02-03 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
US6784165B1 (en) 1999-11-23 2004-08-31 Aderis Pharmaceuticals, Inc. Treatment of heart rhythm disturbances with N6-substituted-5′-(N-substituted) carboxamidoadenosines
US6664252B2 (en) 1999-12-02 2003-12-16 Osi Pharmaceuticals, Inc. 4-aminopyrrolo[2,3-d]pyrimidine compounds specific to adenosine A2a receptor and uses thereof
US6680322B2 (en) 1999-12-02 2004-01-20 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptors and uses thereof
US7160890B2 (en) 1999-12-02 2007-01-09 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
US6294522B1 (en) * 1999-12-03 2001-09-25 Cv Therapeutics, Inc. N6 heterocyclic 8-modified adenosine derivatives
GB9930077D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Medicaments
GB9930083D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Medicaments
US6680324B2 (en) 2000-12-01 2004-01-20 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptors and uses thereof
US6673802B2 (en) 2000-12-01 2004-01-06 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
GB0106867D0 (en) * 2001-03-20 2001-05-09 Glaxo Group Ltd Process
EP1258247A1 (en) * 2001-05-14 2002-11-20 Aventis Pharma Deutschland GmbH Adenosine analogues for the treatment of insulin resistance syndrome and diabetes
JP2005529062A (ja) 2001-11-30 2005-09-29 オーエスアイ・ファーマスーティカルズ・インコーポレーテッド アデノシンａ１及びａ３受容体に特異的な化合物とその使用
EP1465631B1 (en) 2001-12-20 2010-02-24 OSI Pharmaceuticals, Inc. Pyrimidine a2b selective antagonist compounds, their synthesis and use
CN101973998A (zh) 2001-12-20 2011-02-16 Osi药物公司 吡咯并嘧啶A2b选择性拮抗剂化合物
MXPA05011428A (es) * 2003-04-24 2006-05-31 Aderis Pharmaceuticals Inc Metodo de tratamiento de fibrilacion atrial o trepidacion auricular.
TWI393560B (zh) * 2003-05-02 2013-04-21 Japan Tobacco Inc 包含ｓ-〔２（〔〔１-（２-乙基丁基）環己基〕羰基〕胺基）苯基〕２-甲基丙烷硫酯及ｈｍｇ輔酶ａ還原酶抑制劑之組合
WO2005025545A2 (en) * 2003-09-17 2005-03-24 Aderis Pharmaceuticals, Inc. Pharmaceutical formulation for controlled release of selodenoson
AU2006320578B2 (en) * 2005-11-30 2013-01-31 Inotek Pharmaceuticals Corporation Purine derivatives and methods of use thereof
CN101712709A (zh) * 2008-10-06 2010-05-26 中国医学科学院药物研究所 三乙酰基-3-羟基苯基腺苷及其调血脂的用途
BR112012004523A2 (pt) 2009-08-31 2015-09-08 Lonza Ag processo para a preparação de (1s,4r)-2-oxa-3-azabiciclo[2.2.1]hept-5-enos
TWI677489B (zh) 2014-06-20 2019-11-21 美商基利科學股份有限公司 多環型胺甲醯基吡啶酮化合物之合成

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130136C (it) * 1966-10-20
NL6717061A (it) * 1966-12-21 1968-06-24
DE2052596A1 (de) * 1970-10-27 1972-05-04 Boehringer Mannheim Gmbh, 6800 Mannheim Neuartige Verwendung von N(6)-substituierten Adenosin-Derivaten
NL7203984A (it) * 1971-04-10 1972-10-12
BE788958A (fr) * 1971-09-18 1973-03-19 Schering Ag Derives d'adenosine et leur procede de preparation
DE2148838A1 (de) * 1971-09-30 1973-04-05 Boehringer Mannheim Gmbh Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
DE2157036A1 (de) * 1971-11-17 1973-05-24 Boehringer Mannheim Gmbh Neue heterocyclisch substituierte nebularin-derivate und verfahren zu deren herstellung
DE2244328A1 (de) * 1972-09-09 1974-03-21 Boehringer Mannheim Gmbh Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
DE2338705A1 (de) * 1973-07-31 1975-02-13 Boehringer Mannheim Gmbh Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
DE2338963A1 (de) * 1973-08-01 1975-02-13 Boehringer Mannheim Gmbh Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
DE2426682A1 (de) * 1974-06-01 1975-12-11 Boehringer Mannheim Gmbh Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
ZA857998B (en) * 1984-10-26 1986-05-28 Warner Lambert Co N6-substituted adenosines
AU579412B2 (en) * 1984-10-26 1988-11-24 Warner-Lambert Company N` - substituted adenosines

Also Published As

Publication number Publication date
HU203364B (en) 1991-07-29
AU2740188A (en) 1989-06-29
HUT48903A (en) 1989-07-28
IL88765A (en) 1993-04-04
CN1035295A (zh) 1989-09-06
GR1000307B (el) 1992-05-12
KR890009967A (ko) 1989-08-05
IE883845L (en) 1989-06-23
HK1009650A1 (en) 1999-06-04
EP0322242A3 (en) 1990-04-18
CZ403991A3 (en) 1993-04-14
EP0322242B1 (en) 1998-04-01
DE3856154D1 (de) 1998-05-07
IT1224840B (it) 1990-10-24
RU2060996C1 (ru) 1996-05-27
GB8829983D0 (en) 1989-02-15
GB8729994D0 (en) 1988-02-03
DK170894B1 (da) 1996-03-04
AU612747B2 (en) 1991-07-18
ATA315488A (de) 1994-02-15
MX14331A (es) 1993-12-01
NO171506C (no) 1993-03-24
AU8589491A (en) 1991-12-12
CA1320195C (en) 1993-07-13
FI885943A (fi) 1989-06-24
CN1024198C (zh) 1994-04-13
NO885719D0 (no) 1988-12-22
US5032583A (en) 1991-07-16
DE3843609A1 (de) 1989-07-06
NO885719L (no) 1989-06-26
PT89328A (pt) 1989-12-29
DE3856154T2 (de) 1998-08-27
SE8804609D0 (sv) 1988-12-21
FI90429B (fi) 1993-10-29
IE61302B1 (en) 1994-10-19
JPH01203400A (ja) 1989-08-16
RU1826971C (ru) 1993-07-07
IL88765A0 (en) 1989-07-31
SG44701A1 (en) 1997-12-19
FR2629715A1 (fr) 1989-10-13
FI90429C (fi) 1994-02-10
GB2212498B (en) 1991-07-24
NO171506B (no) 1992-12-14
CH677495A5 (it) 1991-05-31
DK713488D0 (da) 1988-12-21
IT8848714A0 (it) 1988-12-23
DK713488A (da) 1989-06-24
NZ227485A (en) 1991-06-25
JP2736088B2 (ja) 1998-04-02
BE1002167A5 (fr) 1990-08-28
NL8803140A (nl) 1989-07-17
ES2012927A6 (es) 1990-04-16
SE8804609L (sv) 1989-06-24
PL158800B1 (en) 1992-10-30
PT89328B (pt) 1993-08-31
ZA889593B (en) 1989-09-27
FR2629715B1 (fr) 1993-09-03
GB2212498A (en) 1989-07-26
YU234188A (en) 1990-12-31
PH25932A (en) 1991-12-19
EP0322242A2 (en) 1989-06-28
PL276697A1 (en) 1990-02-19

Similar Documents

Publication Publication Date Title
LU87414A1 (fr) Derives de l'adenosine
EP0591057B1 (fr) Arylalkyl(thio)amides ayant une affinité sélective pour les récepteurs de la mélatonine et leur procédé de préparation
FR2612516A1 (fr) Derives de benzoxazole et preparation les contenant
CH664152A5 (fr) Derives de tetrahydrocarbazolones.
CH672637A5 (it)
EP0885234A1 (fr) Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
WO2005118547A1 (fr) Derives de tetrahydroisoquinolilsulfonamides, leur preparation et leur utilisation en therapeutique
CH667454A5 (fr) Derives d'indoles.
BE1000072A4 (fr) Derives de l'indole utiles comme medicaments et procede et intermediaires pour leur preparation.
EP0109866B1 (fr) Nouveaux dérivés de la sulfonylurée, leurs procédés de préparation et les compositions pharmaceutiques les renfermant
EP0004494B1 (fr) Nouveaux dérivés de 1,3-dihydro 3-(1-(2-(2,3-dihydro 1,4-benzo-dioxin-2-yl)2-hydroxy éthyl)pipéridin-4-yl)2H-indol 2-one, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant
WO2001017989A2 (fr) Heteroaryloxypropanolamines comme agonistes du recepteur beta3-adrenergique
EP1242389B1 (fr) Nouveaux derives amino substitues ramifies du 3-amino-1-phenyl-1h[1,2,4]triazole, procedes pour leur preparation et compositions pharmaceutiques les contenant
BE1000039A4 (fr) Nouvelles 8 alpha-acylamino-ergolines, leur preparation et leur utilisation comme medicaments.
EP1651596B1 (fr) Derives de 4,4'-dithiobis-(3-aminobutane-1-sulfonates) nouveaux et compositions les contenant
BE1005612A5 (fr) Derive de la dichloroaniline.
FR2663936A1 (fr) Derives de l'adenosine, leur procede de preparation et leur utilisation en therapeutique.
FR2500454A1 (fr) Nouveaux derives de l'ergoline, leur preparation et leur application comme medicaments
EP0427605B1 (fr) Nouveaux dérivés de la morpholine, leur procédé de préparation et les compositions pharmaceutiques les renfermant
FR2719047A1 (fr) Nouveaux dérivés de benzylamines, leur procédé de fabrication et les compositions pharmaceutiques les renfermant.
FR2523129A1 (fr) Derives de 3-azetidinylethyl-1-phenyl-2-imidazolidinone, medicaments les contenant et procede pour leur preparation
FR2729141A1 (fr) Nouveaux derives de carbazole, leur procede de preparation et leur utilisation en tant que medicaments et notamment en tant qu'agents anti-arythmiques
BE889639A (fr) 11-alpha-amino-androstanes, leur preparation et compositions en contenant
WO1983004022A1 (fr) Nouvelles phenyloxoalcoyle piperidines, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
EP0384812A1 (fr) Trifluorométhoxy-5 benzimidazolamine-2, procédé pour sa préparation et médicaments la contenant